Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results

Spatially Resolved and Quantitative Analysis of the Immunological Landscape in Human Meningiomas

(2021) Jacky Yeung et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

The mutational constraint spectrum quantified from variation in 141,456 humans

(2020) Konrad J. Karczewski et al.   NATURE

NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomas

(2020) John W. Rutland et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers

(2020) Paul Riviere et al.   MOLECULAR CANCER THERAPEUTICS

Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes

(2019) Abdurrahman I. Islim et al.   JOURNAL OF NEURO-ONCOLOGY

Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade

(2019) Steve Lu et al.   JAMA Oncology

Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging

(2019) Ziming Du et al.   Nature Protocols

Meningiomas: skull base versus non-skull base

(2018) Torstein R. Meling et al.   NEUROSURGICAL REVIEW

Differential Tumor Progression Patterns in Skull Base Versus Non–Skull Base Meningiomas: A Critical Analysis from a Long-Term Follow-Up Study and Review of Literature

(2018) Amey R. Savardekar et al.   World Neurosurgery

Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes

(2018) Jia-Ren Lin et al.   eLife

PD-L1 expression in meningiomas

(2018) Mahlon D. Johnson   JOURNAL OF CLINICAL NEUROSCIENCE

Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group

(2018) Raymond Y Huang et al.   NEURO-ONCOLOGY

Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy

(2018) Razvan Cristescu et al.   SCIENCE

Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation

(2018) Zachary S. Buchwald et al.   Frontiers in Oncology

The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria

(2017) Lakshmi Nayak et al.   NEURO-ONCOLOGY

First FDA Approval Agnostic of Cancer Site — When a Biomarker Defines the Indication

(2017) Steven Lemery et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tumor Mutational Burden and Response Rate to PD-1 Inhibition

(2017) Mark Yarchoan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma

(2016) Seunggu J. Han et al.   JOURNAL OF NEURO-ONCOLOGY

EANO guidelines for the diagnosis and treatment of meningiomas

(2016) Roland Goldbrunner et al.   LANCET ONCOLOGY

Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review

(2015) Leland Rogers et al.   JOURNAL OF NEUROSURGERY

Immunotherapy response assessment in neuro-oncology: a report of the RANO working group

(2015) Hideho Okada et al.   LANCET ONCOLOGY

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

(2015) Stephen M. Ansell et al.   NEW ENGLAND JOURNAL OF MEDICINE

Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma

(2015) Ziming Du et al.   Oncotarget

Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy

(2014) J. M. Taube et al.   CLINICAL CANCER RESEARCH

Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review

(2014) T. Kaley et al.   NEURO-ONCOLOGY

ClinVar: public archive of relationships among sequence variation and human phenotype

(2013) Melissa J. Landrum et al.   NUCLEIC ACIDS RESEARCH

Atypical Meningioma: A Study of Prognostic Factors

(2013) Ahmed Zaher et al.   World Neurosurgery

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

(2012) Suzanne L. Topalian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

(2010) Patrick Y. Wen et al.   JOURNAL OF CLINICAL ONCOLOGY

A review of malignant meningiomas: diagnosis, characteristics, and treatment

(2010) Simon Hanft et al.   JOURNAL OF NEURO-ONCOLOGY